157 related articles for article (PubMed ID: 25916872)
1. Connective tissue growth factor and the cicatrization of cellular crescents in ANCA-associated glomerulonephritis.
Hilhorst M; Kok HM; Broekhuizen R; van Paassen P; van Breda Vriesman P; Goldschmeding R; Nguyen TQ; Cohen Tervaert JW;
Nephrol Dial Transplant; 2015 Aug; 30(8):1291-9. PubMed ID: 25916872
[TBL] [Abstract][Full Text] [Related]
2. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
[TBL] [Abstract][Full Text] [Related]
3. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study.
Diaz-Crespo F; Villacorta J; Acevedo M; Cavero T; Guerrero C; García Díaz E; Orradre JL; Martinez MA; Praga M; Fernandez-Juarez G
Hum Pathol; 2016 Jun; 52():119-27. PubMed ID: 26980047
[TBL] [Abstract][Full Text] [Related]
5. Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis.
Droguett A; Valderrama G; Burgos ME; Carpio D; Saka C; Egido J; Ruiz-Ortega M; Mezzano S
Sci Rep; 2019 May; 9(1):6867. PubMed ID: 31053735
[TBL] [Abstract][Full Text] [Related]
6. Urinary angiotensinogen: an indicator of active antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Wu L; Yang M; Feng X; Jin L; Wu C; Cui S; Zhou Z; Zhong X; Shi M; Yang Z; Cao W
Nephrol Dial Transplant; 2019 May; 34(5):838-847. PubMed ID: 29733413
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic spectrum of crescentic glomerulonephritis: a hospital-based study.
Choudhury TA; Singh RG; ; Singh S; Singh TB; Rathore SS;
Saudi J Kidney Dis Transpl; 2014 May; 25(3):689-96. PubMed ID: 24821180
[TBL] [Abstract][Full Text] [Related]
8. Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Taniguchi Y; Yorioka N; Yamashita K; Masaki T; Yamakido M
Clin Nephrol; 2000 Aug; 54(2):147-50. PubMed ID: 10968692
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis.
Kanemoto K; Usui J; Tomari S; Yokoi H; Mukoyama M; Aten J; Weening JJ; Nagata M
Lab Invest; 2003 Nov; 83(11):1615-25. PubMed ID: 14615415
[TBL] [Abstract][Full Text] [Related]
11. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
12. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis.
Quintana LF; Peréz NS; De Sousa E; Rodas LM; Griffiths MH; Solé M; Jayne D
Nephrol Dial Transplant; 2014 Sep; 29(9):1764-9. PubMed ID: 24748668
[TBL] [Abstract][Full Text] [Related]
13. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
[TBL] [Abstract][Full Text] [Related]
14. Estimating renal survival using the ANCA-associated GN classification.
Hilhorst M; Wilde B; van Breda Vriesman P; van Paassen P; Cohen Tervaert JW;
J Am Soc Nephrol; 2013 Sep; 24(9):1371-5. PubMed ID: 23766532
[TBL] [Abstract][Full Text] [Related]
15. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
[TBL] [Abstract][Full Text] [Related]
16. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients.
Hauer HA; Bajema IM; Van Houwelingen HC; Ferrario F; Noël LH; Waldherr R; Jayne DR; Rasmussen N; Bruijn JA; Hagen EC;
Kidney Int; 2002 Nov; 62(5):1732-42. PubMed ID: 12371974
[TBL] [Abstract][Full Text] [Related]
17. Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese.
Hung PH; Chiu YL; Lin WC; Chiang WC; Chen YM; Lin SL; Wu KD; Tsai TJ
J Formos Med Assoc; 2006 Oct; 105(10):804-12. PubMed ID: 17000453
[TBL] [Abstract][Full Text] [Related]
18. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases.
Haas M; Eustace JA
Kidney Int; 2004 Jun; 65(6):2145-52. PubMed ID: 15149327
[TBL] [Abstract][Full Text] [Related]
19. [Pathology of the ANCA-associated vasculitides].
Ferrario F; Vanzati A; Pilla D; Pagni F
G Ital Nefrol; 2013; 30(2):. PubMed ID: 23832458
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.
Tanna A; Guarino L; Tam FW; Rodriquez-Cubillo B; Levy JB; Cairns TD; Griffith M; Tarzi RM; Caplin B; Salama AD; Cook T; Pusey CD
Nephrol Dial Transplant; 2015 Jul; 30(7):1185-92. PubMed ID: 25016608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
